CVAC Stock Alert: CureVac Pops on Licensing Deal With GSK

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

CureVac stock is up on Wednesday as CVAC investors react to the company signing a new 1.4 billion euro licensing agreement with GSK.

The post CVAC Stock Alert: CureVac Pops on Licensing Deal With GSK appeared first on InvestorPlace.

More From InvestorPlace

• The #1 AI Investment Might Be This Company You’ve Never Heard Of
• Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
• Legendary Investor Predicts: “Forget A.I. THIS Technology Is the Future”